|
|
Exchange: |
N/A |
Security
Type: |
N/A |
Shares
Out: |
35,410,000 |
Market
Cap: |
13.82(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$202.16 - $413.31 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 463 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Medpace Holdings is a holding company. Through its subsidiaries, Co. is a clinical contract research organization focused on providing scientifically-driven outsourced clinical development services to the biotechnology, pharmaceutical and medical device industries. Co. provides a suite of services supporting the clinical development process from Phase I to Phase IV across a range of therapeutic areas. Co.'s services include medical department, clinical trial management, study start-up, patient recruitment and retention, clinical monitoring, risk-based monitoring, regulatory affairs, medical writing, biometrics and data sciences, pharmacovigilance, and quality assurance.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
2,000,000 |
Total Buy Value |
$0 |
$0 |
$0 |
$309,116,534 |
Total People Bought |
0 |
0 |
0 |
2 |
Total Buy Transactions |
0 |
0 |
0 |
34 |
Total Shares Sold |
1,827,736 |
2,490,136 |
3,605,616 |
3,694,042 |
Total Sell Value |
$734,360,254 |
$918,029,204 |
$1,190,266,600 |
$1,209,941,112 |
Total People Sold |
6 |
6 |
8 |
8 |
Total Sell Transactions |
45 |
71 |
88 |
95 |
End Date |
2024-02-11 |
2023-11-10 |
2023-05-12 |
2022-05-12 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Medpace Investors, Llc |
10% Owner |
|
2019-01-18 |
4 |
AS |
$61.43 |
$2,353,875 |
D/D |
(38,318) |
8,096,225 |
|
- |
|
Troendle August J. |
President & CEO |
|
2019-01-18 |
4 |
AS |
$61.43 |
$2,353,875 |
I/I |
(38,318) |
8,096,225 |
|
- |
|
Medpace Investors, Llc |
10% Owner |
|
2019-01-17 |
4 |
AS |
$61.17 |
$535,849 |
D/D |
(8,760) |
8,134,543 |
|
- |
|
Troendle August J. |
President & CEO |
|
2019-01-17 |
4 |
AS |
$61.17 |
$535,849 |
I/I |
(8,760) |
8,134,543 |
|
- |
|
Medpace Investors, Llc |
10% Owner |
|
2019-01-16 |
4 |
AS |
$61.57 |
$444,659 |
D/D |
(7,222) |
8,143,303 |
|
- |
|
Troendle August J. |
President & CEO |
|
2019-01-16 |
4 |
AS |
$61.57 |
$444,659 |
I/I |
(7,222) |
8,143,303 |
|
- |
|
Medpace Investors, Llc |
10% Owner |
|
2019-01-15 |
4 |
AS |
$61.00 |
$36,600 |
D/D |
(600) |
8,150,525 |
|
- |
|
Troendle August J. |
President & CEO |
|
2019-01-15 |
4 |
AS |
$61.00 |
$36,600 |
I/I |
(600) |
8,150,525 |
|
- |
|
Medpace Investors, Llc |
10% Owner |
|
2018-09-28 |
4/A |
D |
$59.91 |
$44,596,105 |
D/D |
(744,385) |
8,151,125 |
|
- |
|
Troendle August J. |
President & CEO |
|
2018-09-28 |
4/A |
D |
$59.91 |
$44,596,105 |
I/I |
(744,385) |
8,151,125 |
|
- |
|
Medpace Investors, Llc |
10% Owner |
|
2018-09-28 |
4/A |
D |
$59.91 |
$44,779,969 |
D/D |
(747,454) |
8,148,056 |
|
- |
|
Troendle August J. |
President & CEO |
|
2018-09-28 |
4/A |
D |
$59.91 |
$44,779,969 |
I/I |
(747,454) |
8,148,056 |
|
- |
|
Troendle August J. |
President & CEO |
|
2018-09-28 |
4 |
A |
$59.91 |
$15,088,393 |
D/D |
251,851 |
603,702 |
|
- |
|
Troendle August J. |
President & CEO |
|
2018-09-28 |
4 |
D |
$59.91 |
$44,840,179 |
I/I |
(748,459) |
8,147,051 |
|
- |
|
Geiger Jesse J |
CFO & COO, Lab Operations |
|
2018-09-28 |
4 |
A |
$59.91 |
$2,218,887 |
D/D |
37,037 |
37,037 |
|
- |
|
Burwig Susan E |
Exec. VP, Operations |
|
2018-09-28 |
4 |
A |
$59.91 |
$1,508,833 |
D/D |
25,185 |
44,396 |
|
- |
|
Ewald Stephen P |
General Counsel & Corp. Secy. |
|
2018-09-28 |
4 |
A |
$59.91 |
$476,045 |
D/D |
7,946 |
7,946 |
|
- |
|
Medpace Investors, Llc |
10% Owner |
|
2018-09-28 |
4 |
D |
$59.91 |
$44,840,179 |
D/D |
(748,459) |
8,147,051 |
|
- |
|
Medpace Investors, Llc |
10% Owner |
|
2018-09-27 |
4 |
AS |
$58.96 |
$2,758,031 |
D/D |
(46,778) |
8,895,510 |
|
- |
|
Troendle August J. |
President & CEO |
|
2018-09-27 |
4 |
AS |
$58.96 |
$2,758,031 |
I/I |
(46,778) |
8,895,510 |
|
- |
|
Medpace Investors, Llc |
10% Owner |
|
2018-09-26 |
4 |
AS |
$58.38 |
$2,737,205 |
D/D |
(46,886) |
8,942,288 |
|
- |
|
Troendle August J. |
President & CEO |
|
2018-09-26 |
4 |
AS |
$58.38 |
$2,737,205 |
I/I |
(46,886) |
8,942,288 |
|
- |
|
Medpace Investors, Llc |
10% Owner |
|
2018-09-25 |
4 |
AS |
$58.36 |
$2,255,030 |
D/D |
(38,640) |
8,989,174 |
|
- |
|
Troendle August J. |
President & CEO |
|
2018-09-25 |
4 |
AS |
$58.36 |
$2,255,030 |
I/I |
(38,640) |
8,989,174 |
|
- |
|
Troendle August J. |
President & CEO |
|
2018-09-21 |
4 |
AS |
$58.47 |
$158,629 |
I/I |
(2,713) |
9,027,814 |
|
- |
|
533 Records found
|
|
Page 20 of 22 |
|
|